Lurbinectedin Plus Irinotecan Is Safe, Prolongs Responses in

Clinical benefit generated from treatment with lurbinectedin plus irinotecan was noted across sensitive and resistant patient populations with SCLC.

Related Keywords

Spain , Luisg Paz , , Oncology Department , Medical Oncology Department , Hospital Universitario , Universidad Complutense De Madrid ,